- Home
- UEIC vs MREO Comparison
UEIC vs MREO Comparison
Compare UEIC & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UEIC | MREO |
|---|---|---|
| Founded | 1986 | 2015 |
| Country | United States | United Kingdom |
| Employees | N/A | 39 |
| Industry | Consumer Electronics/Appliances | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.3M | 52.5M |
| IPO Year | 1995 | 2017 |
Fundamental Metrics
Financial Performance| Metric | UEIC | MREO |
|---|---|---|
| Price | $4.09 | $0.31 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $3.50 | $1.50 |
| AVG Volume (30 Days) | 69.0K | ★ 1.3M |
| Earning Date | 03-12-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.78 | 16.67 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $368,288,000.00 | $500,000.00 |
| Revenue This Year | N/A | $6,756.00 |
| Revenue Next Year | N/A | $38.65 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.69 | $0.20 |
| 52 Week High | $7.50 | $2.94 |
Technical Indicators
Market Signals| Indicator | UEIC | MREO |
|---|---|---|
| Relative Strength Index (RSI) | 51.40 | 31.69 |
| Support Level | $3.62 | $0.20 |
| Resistance Level | $4.23 | $0.42 |
| Average True Range (ATR) | 0.20 | 0.03 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 52.78 | 1.69 |
Price Performance
Historical ComparisonAbout UEIC Universal Electronics Inc.
Universal Electronics Inc is a United States-based company that principally designs, develops, manufactures, ships, and supports control and sensor technology solutions and a broad line of universal control systems, audio-video (AV) accessories, wireless security, and smart home products that are used by the world's brands in the video services, consumer electronics, security, home automation, climate control and home appliance markets. It generates its total revenue from the United States.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).